New report shows that some premiums and deductibles were lower for 2019-and that members are using new tools to help them save.
During the 2019 Medicare Annual Enrollment Period (AEP), analysis of the plan selections of people shopping for Medicare coverage through eHealth websites shows an average decline in Medicare Advantage premiums of 42%.
This is according to a new report by eHealth, Inc., a leading private online health insurance exchange where individuals, families and small businesses can compare and purchase health insurance products. The report also shows evidence of lower deductibles and out-of-pocket-limits among the plans selected by beneficiaries who purchased Medicare Advantage, Medicare Part D, or Medicare Supplement plans through websites operated by eHealth. However, the report also shows that premium costs among beneficiaries purchasing Medicare Supplement products rose by an average 8%.
In addition, the report finds that use of online transparency tools that enable beneficiaries to search for plans accepted by their preferred medical providers and covering their prescription drugs dramatically increased during the AEP for 2019 coverage.
“Managed care executives are essential health plan leaders who supervise the operations of healthcare systems designed to deliver medical services in ways that improve quality and reduce costs,” says Chris Hakim, vice president and general manager of Medicare at eHealth. “With the rapid movement to value-based care, the executives that truly partner with patients in the management of their health will drive the best results. Of note is that Medicare Advantage is growing rapidly and that is connecting Medicare beneficiaries to tools to help them make better health choices in terms of disease management and in choosing cost-effective services with better health outcomes.”
Related: HHS’ Plan to Lower Medicare Part B Prescription Drug Prices: 5 Things to Know
Other report findings include:
Online transparency tools are becoming more powerful and easier to use, according to Hakim.
“The fact that more Medicare eligible people are buying plans online and using drug transparency tools underscore that when user-friendly technology tools are made available, seniors are increasingly inclined to use them,” says Hakim. “When coupled with the fact that there are 10,000 people becoming Medicare eligible each day-and that ‘younger’ seniors are more tech savvy-it opens the door for more effective, less-expensive communications with Medicare beneficiaries. The tools will only get better as companies are investing more and more in technology.”
Mostafa Kamal Talks Prime Therapeutics, Magellan Rx Integration, the Organization's Trajectory, More
September 13th 2023Managed Healthcare Executive's Managing Editor Peter Wehrwein, and Editor Briana Contreras, had a discussion in July with Mostafa Kamal, president and CEO of Prime Therapeutics, an organization in which Kamal acquired this position that same month.
Listen
Takeda to Withdraw Oncology Drug Exkivity from U.S. Market
October 2nd 2023In a confirmatory trial, Exkivity did not meet the primary endpoint in treating patients with non-small cell lung cancer with EGFR exon 20 mutations. It will remain available while Takeda works with the FDA on withdrawal timing.
Read More
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
2 Clarke Drive
Cranbury, NJ 08512